TBPMF
Price:
$0.0009
Market Cap:
$10.58M
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development...[Read more]
Industry
Biotechnology
IPO Date
2012-09-25
Stock Exchange
OTC
Ticker
TBPMF
According to Tetra Bio-Pharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -98.98% compared to the average of -2.20 of the last 4 quarters.
The mean historical PE Ratio of Tetra Bio-Pharma Inc. over the last ten years is -21.55. The current -0.02 PE Ratio has changed -89.56% with respect to the historical average. Over the past ten years (40 quarters), TBPMF's PE Ratio was at its highest in in the November 2012 quarter at 248.83. The PE Ratio was at its lowest in in the February 2016 quarter at -168.42.
Average
-21.55
Median
-15.63
Minimum
-60.62
Maximum
-1.78
Discovering the peaks and valleys of Tetra Bio-Pharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 409.36%
Maximum Annual PE Ratio = -1.78
Minimum Annual Increase = -77.78%
Minimum Annual PE Ratio = -60.62
| Year | PE Ratio | Change |
|---|---|---|
| 2021 | -1.84 | 3.39% |
| 2020 | -1.78 | -60.06% |
| 2019 | -4.45 | -77.78% |
| 2018 | -20.01 | 77.77% |
| 2017 | -11.26 | -70.52% |
| 2016 | -38.18 | -37.01% |
| 2015 | -60.62 | 47.12% |
| 2014 | -41.20 | 409.36% |
| 2013 | -8.09 | -71.16% |
| 2012 | -28.05 | 229.44% |
The current PE Ratio of Tetra Bio-Pharma Inc. (TBPMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.69
5-year avg
-7.86
10-year avg
-21.55
Tetra Bio-Pharma Inc.’s PE Ratio is greater than Immune Therapeutics, Inc. (-0.58), greater than Forward Pharma A/S (-3.88), greater than Bionomics Limited (-0.03), greater than Polydex Pharmaceuticals Limited (-2.77), greater than MDxHealth S.A. (-5.41), greater than Tryp Therapeutics Inc. (-1.10), greater than HealthBeacon plc (-0.55), greater than Top Strike Resources Corp. (-0.42), greater than Intellipharmaceutics International Inc. (-1.72), greater than Carebook Technologies Inc. (-0.15),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.58 | $7.78M | |
| -3.88 | $7.45M | |
| -0.03 | $8.81M | |
| -2.77 | $6.82M | |
| -5.41 | $8.65M | |
| -1.10 | $5.42M | |
| -0.55 | $8.44M | |
| -0.42 | $8.45M | |
| -1.72 | $4.96M | |
| -0.15 | $6.84M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tetra Bio-Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tetra Bio-Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Tetra Bio-Pharma Inc.'s PE Ratio?
How is the PE Ratio calculated for Tetra Bio-Pharma Inc. (TBPMF)?
What is the highest PE Ratio for Tetra Bio-Pharma Inc. (TBPMF)?
What is the 3-year average PE Ratio for Tetra Bio-Pharma Inc. (TBPMF)?
What is the 5-year average PE Ratio for Tetra Bio-Pharma Inc. (TBPMF)?
How does the current PE Ratio for Tetra Bio-Pharma Inc. (TBPMF) compare to its historical average?